Monika Bar-Rudzinska

Krakow, MA, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

The role of botulinum toxin in the multimodal management of pain in Parkinson's disease: a scoping review.

The role of botulinum toxin in the multimodal management of pain in Parkinson's disease: a scoping review.

Journal: Journal of neural transmission (Vienna, Austria : 1996)

Published: May 10, 2026

Pace-Induced Saccades in Essential Tremor Differ from Those in Parkinson's Disease and Degenerative Ataxias.

Pace-Induced Saccades in Essential Tremor Differ from Those in Parkinson's Disease and Degenerative Ataxias.

Journal: Journal of clinical medicine

Published: March 25, 2026

GRU-Based Deep Multimodal Fusion of Speech and Head-IMU Signals in Mixed Reality for Parkinson's Disease Detection.

GRU-Based Deep Multimodal Fusion of Speech and Head-IMU Signals in Mixed Reality for Parkinson's Disease Detection.

Journal: Sensors (Basel, Switzerland)

Published: October 22, 2025

The Assessment of RAB32 p.Ser71Arg Variant Prevalence in Parkinson's Disease Across Selected African, European, and South American Cohorts.

The Assessment of RAB32 p.Ser71Arg Variant Prevalence in Parkinson's Disease Across Selected African, European, and South American Cohorts.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: October 15, 2025

Dysfunctions of sleep and the circadian rhythm in Huntington's disease.

Dysfunctions of sleep and the circadian rhythm in Huntington's disease.

Journal: Frontiers in neurology

Published: August 26, 2025

PPM1M, an LRRK2-counteracting, phosphoRab12-preferring phosphatase with a potential link to Parkinson's disease.

PPM1M, an LRRK2-counteracting, phosphoRab12-preferring phosphatase with a potential link to Parkinson's disease.

Journal: Cell reports

Published: April 07, 2025

PPM1M, a LRRK2-counteracting, phosphoRab12-preferring phosphatase with potential link to Parkinson's disease.

PPM1M, a LRRK2-counteracting, phosphoRab12-preferring phosphatase with potential link to Parkinson's disease.

Journal: bioRxiv : the preprint server for biology

Published: April 01, 2025

Validation of the Polish version of the Movement Disorder Society Non-motor Rating Scale (MDS-NMS).

Validation of the Polish version of the Movement Disorder Society Non-motor Rating Scale (MDS-NMS).

Journal: Neurologia i neurochirurgia polska

Published: March 09, 2025

Challenges of equitable access to device-aided therapies for advanced Parkinson's Disease in Poland - expert consensus and treatment recommendations.

Challenges of equitable access to device-aided therapies for advanced Parkinson's Disease in Poland - expert consensus and treatment recommendations.

Journal: Neurologia i neurochirurgia polska

Published: September 19, 2024

Reflexive and voluntary saccadic eye movements as biomarker of Huntington's Disease.

Reflexive and voluntary saccadic eye movements as biomarker of Huntington's Disease.

Journal: Neurologia i neurochirurgia polska

Published: April 28, 2023

Cathepsin B p.Gly284Val Variant in Parkinson's Disease Pathogenesis.

Cathepsin B p.Gly284Val Variant in Parkinson's Disease Pathogenesis.

Journal: International journal of molecular sciences

Published: April 23, 2022

Is deep brain stimulation effective in Huntington's Disease? - a systematic literature review.

Is deep brain stimulation effective in Huntington's Disease? - a systematic literature review.

Journal: Neurologia i neurochirurgia polska

Published: January 05, 2022

Showing 1-12 of 39

Last Updated: 09/26/2026